Co-Diagnostics, Inc. Initiates Vector Control Program in Dominican Republic
Program received enthusiastically by regional Ministries of Health
Vector is the term used to describe an organism that transmits infectious disease across human or animal populations. Ministries and Departments of Health in the U.S. and worldwide currently have vector control services to control, limit, or eradicate vectors where they are suspected to contribute to the spread of pathogens or outbreaks.
Co-Diagnostics’ vector control program will involve the Company’s
diagnostic tests being used by vector control services to test mosquito
populations where the insect is known to act as a vector. The program
has been met with enthusiasm by the Ministries of Health in several
Tests that are not intended to diagnose humans are subject to different
regulatory requirements, which will allow those used in the Company’s
program to be sold throughout
In addition to the vector control program, the Company and a regional
marketing and distribution partner completed a number of sales and
product validation site visits to hospitals and clinical laboratories
This press release contains forward-looking statements. Forward-looking statements can be identified by words such as "believes," "expects," "estimates," "intends," "may," "plans," "will" and similar expressions, or the negative of these words. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions. Readers of this press release are cautioned not to place undue reliance on any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.
This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Co-Diagnostics Investor Relations
Joe Diaz, 602-889-9700